Denemek ALTIN - Özgür
A newly confident China is jockeying for more global clout as Trump pulls back
Mint Chennai
|December 04, 2025
Feeling empowered after a clash over trade, Beijing looks to exploit America’s inward turn
US president Donald Trump (left) with China's president Xi Jinping.
(REUTERS)
China is flexing its muscles, showing new confidence fueled by a belief that President Trump's retreat from overseas commitments and his focus on the Western Hemisphere and trade deals create unique opportunities for Beijing.
As bonds between the U.S. and other democracies come under strain, Beijing’s new assertiveness also stems from pride over China's prowess in future-defining technologies, from artificial intelligence to high-speed rail and clean energy. Those achievements come in parallel with a rapid military buildup.
“Trump is pragmatic, and he sees China rising in hard power and also in soft power. By concentrating on the Americas rather than doing a pivot to Asia and spreading too thin on every front, by retreating while being on good terms with China, the Americans can still maybe maintain their dominance of global affairs for 20 or 30 years,” said Wang Huiyao, founder and president of the Center for China and Globalization think tank in Beijing.
The turning point, the consensus in China’s foreign-policy establishment holds, came after a confrontation over trade tariffs, rare earths and export restrictions ended with a temporary truce struck by Trump and Chinese leader Xi Jinping in South Korea in October.
This climbdown from what one U.S. official described as “an economic equivalent of nuclear war”—barriers that would have deprived China, and the U.S., of vital materials and components—has ushered in a new era in Sino-American relations, many Chinese analysts believe: By striking back hard, China has demonstrated its might, earning peer status for the first time and forcing America to retreat.
Bu hikaye Mint Chennai dergisinin December 04, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Chennai'den DAHA FAZLA HİKAYE
Mint Chennai
Small-town wealthy dive into high-risk PMS schemes
Sophisticated, high-risk investments are no longer confined to the rich in metropolitan cities.
1 min
December 04, 2025
Mint Chennai
‘Targeting public debt appropriate during uncertainty’
India’s shift from targeting annual fiscal deficit to long-term debt was appropriate during a period of external economic uncertainty, chief economic adviser V. Anantha Nageswaran said.
1 mins
December 04, 2025
Mint Chennai
Services PMI rebounds in November
India’s services sector rebounded in November, as new business intakes increased amid subdued price pressures and improving demand, a private sw showed on Wednesday.
2 mins
December 04, 2025
Mint Chennai
Climate chaos: Megacities face rapidly rising risks of flooding
Urban spaces in the tropical monsoon belt are the most vulnerable
3 mins
December 04, 2025
Mint Chennai
Seeking affordable financial advice? Try fixed-fee RIAs
Sebi-registered RIAs earn from client fees, not commissions, ensuring conflict-free guidance
5 mins
December 04, 2025
Mint Chennai
IT sector sheds weight in stock market indices as AI rises
Since the start of the year, shares of the five largest firms have seen sharp drops: TCS fell by 23.47%, Infosys 17%, HCLTech 14.74%, Wipro 17.14%, and Tech Mahindra 9.97%.
2 mins
December 04, 2025
Mint Chennai
IT sheds weight in indices as AI rises
Combined weight of IT cos in BSE Sensex down to 18-year low
1 mins
December 04, 2025
Mint Chennai
JLR CEO Balaji's early trials: top exit, cyberattack impact
Gerry McGovern's abrupt removal has created uncertainty over brand and design strategy
3 mins
December 04, 2025
Mint Chennai
IndiGo flights hit by pilot rest rules, weather, leaves
DGCA probing disruption, working with IndiGo to minimize inconvenience
2 mins
December 04, 2025
Mint Chennai
Natco Pharma's cyclical model leaves revenue outlook cloudy
Shares of Natco Pharma Ltd have dropped 38% from the 52-week high of ₹1,505 (December 2024), as the Street grows cautious about its high-risk, high-reward business model.
1 mins
December 04, 2025
Listen
Translate
Change font size
